Literature DB >> 19898767

Neuroendocrine circuitry and endometriosis: progesterone derivative dampens corticotropin-releasing hormone-induced inflammation by peritoneal cells in vitro.

Nadja Tariverdian1, Mirjam Rücke, Julia Szekeres-Bartho, Sandra M Blois, Eva F Karpf, Peter Sedlmayr, Burghard F Klapp, Heribert Kentenich, Friederike Siedentopf, Petra C Arck.   

Abstract

Clinical symptoms of endometriosis, such as pain and infertility, can be described as persistent stressors. Such continuous exposure to stress may severely affect the equilibrium and bidirectional communication of the endocrine and immune system, hereby further aggravating the progression of endometriosis. In the present study, we aimed to tease apart mediators that are involved in the stress response as well as in the progression of endometriosis. Women undergoing diagnostic laparoscopy due to infertility were recruited (n = 69). Within this cohort, early stage of endometriosis were diagnosed in n = 30 and advanced stage of endometriosis in n = 8. Levels of progesterone in serum were determined. Frequency of progesterone receptor (PR) expression on CD56(+) and CD8(+) peritoneal lymphocytes was analysed by flow cytometry. The production of tumour necrosis factor (TNF) and interleukin (IL)-10 by peritoneal leukocytes upon stimulation with the potent stress mediator corticotropin-releasing hormone (CRH) and the progesterone derivative dydrogesterone, or both, were evaluated. Furthermore, the production of progesterone-induced blocking factor (PIBF) by peritoneal leukocytes and the expression of PR in endometriotic tissue were investigated. Levels of progesterone in serum were decreased in women with endometriosis and inversely correlated to pain scores. Furthermore, an increased frequency of CD56(+)PR(+) and CD8(+)PR(+) peritoneal lymphocytes was present in advanced endometriosis. The TNF/IL-10 ratio, reflecting cytokine secretion by peritoneal cells, was higher in cells derived from endometriosis patients and could be further heightened by CRH stimulation, whereas stimulation with dydrogesterone abrogated the CRH-mediated inflammation. Finally, the expression of PIBF by peritoneal leukocytes was increased in endometriosis. Low levels of progesterone in the follicular phase could be responsible for the progression of endometriosis and related pain. Peripheral CRH, increasing upon high psychological stress, might contribute to the peritoneal inflammation present in endometriosis. The therapeutic application of progesterone derivatives, CRH blocking agents as well as improvement of stress coping may disrupt the vicious circle between the chronic peritoneal inflammation and high perception of psychological stress in endometriosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898767     DOI: 10.1007/s00109-009-0559-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  47 in total

1.  Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study.

Authors:  A Fujishita; P K Nakane; T Koji; H Masuzaki; R O Chavez; T Yamabe; T Ishimaru
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

2.  Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.

Authors:  Raj Raghupathy; Esraa Al Mutawa; Ma'asoumah Makhseed; Fawaz Azizieh; Julia Szekeres-Bartho
Journal:  BJOG       Date:  2005-08       Impact factor: 6.531

3.  Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain.

Authors:  P R Koninckx; C Meuleman; S Demeyere; E Lesaffre; F J Cornillie
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

4.  Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis.

Authors:  Friederike Siedentopf; Nadja Tariverdian; Mirjam Rücke; Heribert Kentenich; Petra C Arck
Journal:  Am J Reprod Immunol       Date:  2008-11       Impact factor: 3.886

5.  Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice.

Authors:  P C Arck; F S Merali; J Manuel; G Chaouat; D A Clark
Journal:  Am J Reprod Immunol       Date:  1995-01       Impact factor: 3.886

6.  Endometriosis in pregnant and non-pregnant women at tubal sterilization.

Authors:  M H Moen; K M Muus
Journal:  Hum Reprod       Date:  1991-05       Impact factor: 6.918

Review 7.  Stress and the female reproductive system.

Authors:  S N Kalantaridou; A Makrigiannakis; E Zoumakis; G P Chrousos
Journal:  J Reprod Immunol       Date:  2004-06       Impact factor: 4.054

8.  Intraperitoneal immune cell status in infertile women with and without endometriosis.

Authors:  N Tariverdian; F Siedentopf; M Rücke; S M Blois; B F Klapp; H Kentenich; P C Arck
Journal:  J Reprod Immunol       Date:  2009-04-18       Impact factor: 4.054

Review 9.  Progestogens for endometriosis: forward to the past.

Authors:  Paolo Vercellini; Luigi Fedele; Giuliana Pietropaolo; Giada Frontino; Edgardo Somigliana; Pier Giorgio Crosignani
Journal:  Hum Reprod Update       Date:  2003 Jul-Aug       Impact factor: 15.610

10.  Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis.

Authors:  J A Keenan; T T Chen; N L Chadwell; D S Torry; M R Caudle
Journal:  Am J Reprod Immunol       Date:  1994-10       Impact factor: 3.886

View more
  8 in total

1.  Stress, inflammation and endometriosis: are patients stuck between a rock and a hard place?

Authors:  Bettina Toth
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

2.  Impact of Psychological Stress on Pain Perception in an Animal Model of Endometriosis.

Authors:  Siomara Hernandez; Myrella L Cruz; Inevy I Seguinot; Annelyn Torres-Reveron; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2017-01-17       Impact factor: 3.060

3.  Peritoneal endometriosis induces time-related depressive- and anxiety-like alterations in female rats: involvement of hippocampal pro-oxidative and BDNF alterations.

Authors:  Paulo Wagner Linhares Lima Filho; Adriano José Maia Chaves Filho; Charliene Freire Xavier Vieira; Tatiana de Queiroz Oliveira; Michelle Verde Ramo Soares; Paloma Marinho Jucá; Joao Quevedo; Tatiana Barichello; Danielle Macedo; Francisco das Chagas Medeiros
Journal:  Metab Brain Dis       Date:  2019-02-23       Impact factor: 3.584

4.  Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model.

Authors:  Marielly Cuevas; Idhaliz Flores; Kenira J Thompson; Dinah L Ramos-Ortolaza; Annelyn Torres-Reveron; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2012-04-23       Impact factor: 3.060

5.  Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation.

Authors:  Aikaterini Vergetaki; Udo Jeschke; Thomas Vrekoussis; Eirini Taliouri; Luca Sabatini; Evangelia A Papakonstanti; Antonis Makrigiannakis
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

6.  Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis.

Authors:  Xiaofang Xu; Xianjun Cai; Sun-Wei Guo; Xishi Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-02-19       Impact factor: 5.211

7.  Differential expression of CRH, UCN, CRHR1 and CRHR2 in eutopic and ectopic endometrium of women with endometriosis.

Authors:  Aikaterini Vergetaki; Udo Jeschke; Thomas Vrekoussis; Eirini Taliouri; Luca Sabatini; Evangelia A Papakonstanti; Antonis Makrigiannakis
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis.

Authors:  Meraj A Khan; Jayasree Sengupta; Suneeta Mittal; Debabrata Ghosh
Journal:  Reprod Biol Endocrinol       Date:  2012-09-24       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.